These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19928382)

  • 21. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection.
    Yorgason JT; Jones SR; España RA
    Neuroscience; 2011 May; 182():125-32. PubMed ID: 21402130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats.
    Galici R; Galli A; Jones DJ; Sanchez TA; Saunders C; Frazer A; Gould GG; Lin RZ; France CP
    Neuroendocrinology; 2003 Feb; 77(2):132-40. PubMed ID: 12624535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release.
    Rothman RB; Dersch CM; Ananthan S; Partilla JS
    J Pharmacol Exp Ther; 2009 May; 329(2):718-28. PubMed ID: 19244097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic role in stimulant-induced wakefulness.
    Wisor JP; Nishino S; Sora I; Uhl GH; Mignot E; Edgar DM
    J Neurosci; 2001 Mar; 21(5):1787-94. PubMed ID: 11222668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
    Krief S; Berrebi-Bertrand I; Nagmar I; Giret M; Belliard S; Perrin D; Uguen M; Robert P; Lecomte JM; Schwartz JC; Finance O; Ligneau X
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00855. PubMed ID: 34423920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142.
    Moerke MJ; Ananthan S; Banks ML; Eltit JM; Freitas KC; Johnson AR; Saini SK; Steele TWE; Negus SS
    J Pharmacol Exp Ther; 2018 Nov; 367(2):222-233. PubMed ID: 30150482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
    Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
    Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
    Lamensdorf I; Porat S; Simantov R; Finberg JP
    Br J Pharmacol; 1999 Feb; 126(4):997-1002. PubMed ID: 10193780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter.
    Gaffaney JD; Vaughan RA
    Mol Pharmacol; 2004 Mar; 65(3):692-701. PubMed ID: 14978248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
    Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.
    Diniz PH; Silva JH; Gomez MV; Guatimosim C; Gomez RS
    Cell Mol Neurobiol; 2007 Sep; 27(6):757-70. PubMed ID: 17680357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
    Goodwin JS; Larson GA; Swant J; Sen N; Javitch JA; Zahniser NR; De Felice LJ; Khoshbouei H
    J Biol Chem; 2009 Jan; 284(5):2978-2989. PubMed ID: 19047053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobeline effects on tonic and methamphetamine-induced dopamine release.
    Wilhelm CJ; Johnson RA; Eshleman AJ; Janowsky A
    Biochem Pharmacol; 2008 Mar; 75(6):1411-5. PubMed ID: 18191815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
    Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
    Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
    Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
    Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.